Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06464926Not ApplicableRecruiting

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

Role: lead

NCT06661668Recruiting

Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis

Role: collaborator

NCT05980455Not ApplicableRecruiting

Study of Enterra Programming with Nocturnal Cycling in Gastroparetics

Role: lead

NCT06560307Not ApplicableRecruiting

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

Role: lead

All 4 trials loaded